# DoD Lung Cancer, Concept Award

Source: https://welltoldgrants.com/grants/w81xwh-21-lcrp-ca-dod-lung-cancer-concept-award/  
Official notice: https://www.grants.gov/search-results-detail/331395

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 12 awards worth $1.9 million in total. Applications closed on April 20, 2021.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-21-LCRP-CA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | April 20, 2021 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 12 |
| Total funding | $1.9 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY21 LCRP Concept Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer. The Concept Award is not intended to support an incremental progression of an already established research project; instead, this award mechanism allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations by supporting high-risk studies that have the potential to reveal entirely new avenues for investigation. Applications must describe how the new idea will enhance the existing knowledge of lung cancer or develop an innovative and novel course of investigation. Research completed through a Concept Award may generate sufficient preliminary data to enable the PI to prepare an application for future research. Presentation of preliminary data is not consistent with the intent of the Concept Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data. Relevance to Military Health: The LCRP seeks to support research that is relevant to the health care needs of military Service members, Veterans, and their families. Relevance to military health will be considered in determining relevance to the mission of the DHP and FY21 LCRP during programmatic review. Investigators are strongly encouraged to consider the following characteristics as examples of how a project may demonstrate relevance to military health: · Use of military or Veteran populations, biospecimens, data/databases, or programs in the proposed research · Collaboration with Department of Defense (DoD) or Department of Veterans Affairs (VA) investigators · Description of how the knowledge, information, products, or technologies gained from the proposed research could be implemented in a dual-use capacity to address a military need that also benefits the civilian population · Explanation of how the project addresses an aspect of lung cancer that has direct relevance tomilitary Service members, Veterans, or other Military Health System beneficiaries, includingenvironmental exposures other than tobacco

## Questions people ask

### Is W81XWH-21-LCRP-CA still open?

No. It closed on April 20, 2021. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Lung Cancer, Concept Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Lung Cancer, Concept Award?

Closed April 20, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $1.9 million in total across about 12 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.